Biotricity (NASDAQ: BTCY) announces the upcoming launch of HeartSecure, the first-ever direct-to-patient cardiac screening service. Targeting the $1.05 billion home heart health market, HeartSecure aims to provide home-based cardiac health checks for 127 million Americans at risk for heart disease. This service addresses long wait times and financial barriers associated with current cardiologist visits.
HeartSecure combines advanced technology with top cardiologists' expertise to detect potential heart issues early. It responds to the growing need for accessible cardiac screenings due to the increasing prevalence of chronic diseases. HeartSecure's launch is seen as a major growth opportunity for Biotricity in the tele-health market, which has expanded significantly post-pandemic.